Literature DB >> 26245737

Editorial: Scleroderma: Bringing a Disease From Black-and-White Into Technicolor.

Colin B Ligon1, Fredrick M Wigley1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26245737      PMCID： PMC4757897          DOI： 10.1002/art.39310

Source DB:  PubMed          Journal:  Arthritis Rheumatol        ISSN： 2326-5191            Impact factor:   10.995


× No keyword cloud information.
  21 in total

1.  Prognostic significance of Raynaud's phenomenon and other clinical characteristics of systemic scleroderma. A study of 271 cases.

Authors:  R G FARMER; R W GIFFORD; E A HINES
Journal:  Circulation       Date:  1960-06       Impact factor: 29.690

2.  Scleroderma (systemic sclerosis): classification, subsets and pathogenesis.

Authors:  E C LeRoy; C Black; R Fleischmajer; S Jablonska; T Krieg; T A Medsger; N Rowell; F Wollheim
Journal:  J Rheumatol       Date:  1988-02       Impact factor: 4.666

3.  A survival study of patients with scleroderma diagnosed over 30 years (1953-1983): the value of a simple cutaneous classification in the early stages of the disease.

Authors:  A J Barnett; M H Miller; G O Littlejohn
Journal:  J Rheumatol       Date:  1988-02       Impact factor: 4.666

4.  Anti-RNA polymerases and other autoantibody specificities in systemic sclerosis.

Authors:  C C Bunn; C P Denton; X Shi-Wen; C Knight; C M Black
Journal:  Br J Rheumatol       Date:  1998-01

5.  Changes in forced vital capacity over time in systemic sclerosis: application of group-based trajectory modelling.

Authors:  Ada Man; Todd Davidyock; Laura T Ferguson; Michael Ieong; Yuqing Zhang; Robert W Simms
Journal:  Rheumatology (Oxford)       Date:  2015-03-17       Impact factor: 7.580

6.  Different antibody patterns and different prognoses in patients with scleroderma with various extent of skin sclerosis.

Authors:  M Giordano; G Valentini; S Migliaresi; U Picillo; M Vatti
Journal:  J Rheumatol       Date:  1986-10       Impact factor: 4.666

7.  The degree of skin involvement identifies distinct lung disease outcomes and survival in systemic sclerosis.

Authors:  Tricia R Cottrell; Robert A Wise; Fredrick M Wigley; Francesco Boin
Journal:  Ann Rheum Dis       Date:  2013-04-20       Impact factor: 19.103

8.  Autoantibody to centromere (kinetochore) in scleroderma sera.

Authors:  Y Moroi; C Peebles; M J Fritzler; J Steigerwald; E M Tan
Journal:  Proc Natl Acad Sci U S A       Date:  1980-03       Impact factor: 11.205

9.  Prediction of pulmonary complications and long-term survival in systemic sclerosis.

Authors:  Svetlana I Nihtyanova; Benjamin E Schreiber; Voon H Ong; Daniel Rosenberg; Pia Moinzadeh; J Gerrard Coghlan; Athol U Wells; Christopher P Denton
Journal:  Arthritis Rheumatol       Date:  2014-06       Impact factor: 10.995

10.  The 'CREST' syndrome. Comparison with systemic sclerosis (scleroderma).

Authors:  E E Velayos; A T Masi; M B Stevens; L E Shulman
Journal:  Arch Intern Med       Date:  1979-11
View more
  2 in total

1.  Considerations for a combined index for limited cutaneous systemic sclerosis to support drug development and improve outcomes.

Authors:  Alain Lescoat; Susan L Murphy; David Roofeh; John D Pauling; Michael Hughes; Robert Sandler; François Zimmermann; Rachel Wessel; Whitney Townsend; Lorinda Chung; Christopher P Denton; Peter A Merkel; Virginia Steen; Yannick Allanore; Francesco Del Galdo; Dominique Godard; David Cella; Sue Farrington; Maya H Buch; Dinesh Khanna
Journal:  J Scleroderma Relat Disord       Date:  2020-10-05

2.  Phenotypes Determined by Cluster Analysis and Their Survival in the Prospective European Scleroderma Trials and Research Cohort of Patients With Systemic Sclerosis.

Authors:  Vincent Sobanski; Jonathan Giovannelli; Yannick Allanore; Gabriela Riemekasten; Paolo Airò; Serena Vettori; Franco Cozzi; Oliver Distler; Marco Matucci-Cerinic; Christopher Denton; David Launay; Eric Hachulla
Journal:  Arthritis Rheumatol       Date:  2019-08-12       Impact factor: 10.995
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.